Filing Details

Accession Number:
0001567619-21-016515
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2021-08-31 17:01:19
Reporting Period:
2021-05-28
Accepted Time:
2021-08-31 17:01:19
Original Submission Date:
2021-06-01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874716 Idexx Laboratories Inc IDXX In Vitro & In Vivo Diagnostic Substances (2835) 010393723
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1740719 V Kathy Turner C/O Idexx Laboratories, Inc.
One Idexx Drive
Westbrook ME 04092
Senior Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-05-28 2,000 $558.44 2,866 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 100 Indirect by spouse
Footnotes
  1. Amendment is being filed to correct the number of shares of Issuer common stock held.
  2. The reporting person disclaims beneficial interest of the shares of common stock held by her spouse except to the extent of her pecuniary interest therein.